ASPE

12.4200.24%
DM

Damien McDevitt

President, CEO & Director

Dr. Damien McDevitt, Ph.D., serves as President, Chief Executive Officer and Director at Aspen Neuroscience, Inc. since January 2021. He served as Chief Executive Officer at Akcea Therapeutics, Inc from September 2019 to from September 2019. He served as Director of Akcea Therapeutics, Inc since October 04, 2018 until October 12, 2020 and served as its Interim Chief Executive Officer since September 23, 2019 until March 25, 2020. A distinguished leader in the biotech and pharmaceutical industry sectors, Dr. McDevitt is recognized for his vision, strategic planning and corporate leadership. Prior to joining Akcea, he held senior executive roles at Ionis Pharmaceuticals, Acadia Pharmaceuticals and GlaxoSmithKline Pharmaceuticals. With a career spanning more than 25 years, he has served in multiple board and executive leadership roles. Dr. McDevitt served as Chief Business Officer of Ionis Pharmaceuticals, Inc. since June 18, 2018 and provided strategic guidance and lead Ionis’ corporate development activities, including corporate communications, business development, patient advocacy, competitive intelligence and alliance management. Prior to joining Ionis, he served as Senior Vice President of Corporate Development at ACADIA Pharmaceuticals Inc. since December 13, 2017 until 2018. Dr. McDevitt joined ACADIA after more than two decades at GlaxoSmithKline plc, where he was at the forefront of the R&D externalization effort and involved in more than 70 global business development transactions spanning a variety of therapeutic areas, including neuroscience. Most recently, he was Vice President, Head of Business Development for R&D Extended Therapy Areas, Head of Worldwide Business Development Asia and Head of its R&D West Coast Satellite. Prior to that, Dr. McDevitt held positions with increasing responsibility within Worldwide Business Development, GSK Ventures and Anti-Infectives Discovery. Dr. McDevitt attended Trinity College in Dublin, Ireland, where he earned his Ph.D. and his undergraduate degree, both in Microbiology.

Positions